[go: up one dir, main page]

DK0426314T3 - HIV-relaterede peptider - Google Patents

HIV-relaterede peptider

Info

Publication number
DK0426314T3
DK0426314T3 DK90311056.7T DK90311056T DK0426314T3 DK 0426314 T3 DK0426314 T3 DK 0426314T3 DK 90311056 T DK90311056 T DK 90311056T DK 0426314 T3 DK0426314 T3 DK 0426314T3
Authority
DK
Denmark
Prior art keywords
hiv
terminal
related peptides
peptides
fragments
Prior art date
Application number
DK90311056.7T
Other languages
English (en)
Inventor
Paul H Naylor
Su Sun Wang
Original Assignee
Univ George Washington
Viral Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23666609&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0426314(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ George Washington, Viral Technologies Inc filed Critical Univ George Washington
Application granted granted Critical
Publication of DK0426314T3 publication Critical patent/DK0426314T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00Cellular immunotherapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/16011Human Immunodeficiency Virus, HIV
    • C12N2740/16211Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK90311056.7T 1989-10-12 1990-10-09 HIV-relaterede peptider DK0426314T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US42046989A 1989-10-12 1989-10-12

Publications (1)

Publication Number Publication Date
DK0426314T3 true DK0426314T3 (da) 1995-03-27

Family

ID=23666609

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90311056.7T DK0426314T3 (da) 1989-10-12 1990-10-09 HIV-relaterede peptider

Country Status (17)

Country Link
EP (3) EP0426314B1 (da)
JP (1) JPH03209398A (da)
KR (1) KR910007962A (da)
CN (1) CN1052310A (da)
AT (1) ATE119166T1 (da)
AU (1) AU6393990A (da)
CA (1) CA2027455A1 (da)
DE (1) DE69017352T2 (da)
DK (1) DK0426314T3 (da)
ES (1) ES2071038T3 (da)
GB (1) GB2236754A (da)
GR (1) GR3015244T3 (da)
HU (1) HUT55035A (da)
IE (1) IE67533B1 (da)
IL (1) IL95890A0 (da)
NZ (1) NZ235538A (da)
ZA (1) ZA907944B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4039925A1 (de) * 1990-12-14 1992-06-17 Behringwerke Ag Ausgewaehlte peptide des gruppenspezifischen antigens (gag) von humanem immundefizienzvirus (hiv), ihre herstellung und verwendung
FR2734281B1 (fr) * 1995-05-18 1997-07-25 Commissariat Energie Atomique Fragments d'acide nucleique derives du genome du virus vih-1, peptides correspondants et leurs applications en tant que reactifs d'evaluation du risque de transmission materno-foetale du vih-1
US6103239A (en) * 1996-08-09 2000-08-15 Cel-Sci Corporation Modified HGP-30 heteroconjugates, compositions and methods of use
NO314588B1 (no) * 2000-09-04 2003-04-14 Bionor Immuno As HIV-peptider, antigener, vaksinesammensetning, immunoassay- testsett og en fremgangsmåte for å påvise antistoffer indusert av HIV
WO2003016337A1 (en) * 2001-08-07 2003-02-27 Medestea Internazionale S.R.L. Isolated polypeptides based on the neutralizing epitope of the p17 protein of hiv useful as vaccines, and neutralizing anti-p17 antibodies which specifically recognize said neutralizing epitope

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6713287A (en) * 1986-01-06 1987-07-09 F. Hoffmann-La Roche & Co. Expression of htlv-iii gag-gene
NZ220200A (en) * 1986-05-19 1990-08-28 Viral Technologies Inc Hiv related peptides, antibodies to the peptides and vaccines therefrom
JPH0762031B2 (ja) * 1986-12-30 1995-07-05 アメリカ合衆国 エイズウイルスおよびエイズウイルスのタンパク質に対する細胞性免疫を誘導する合成ペプチド
NO881151L (no) * 1987-03-27 1988-09-28 Syntello Ab Syntetisk hiv-1-antigen.
DK643188A (da) * 1987-11-24 1989-05-25 Smithkline Biolog Ekspression af hiv-proteiner i e.coli og s.cerevisiae
EP0330359A3 (en) * 1988-02-25 1991-06-05 Bio-Rad Laboratories, Inc. Composition useful in the diagnosis and treating of hiv-1 infection

Also Published As

Publication number Publication date
EP0426314B1 (en) 1995-03-01
KR910007962A (ko) 1991-05-30
IE67533B1 (en) 1996-04-03
GB9021942D0 (en) 1990-11-21
GB2236754A (en) 1991-04-17
IL95890A0 (en) 1991-07-18
DE69017352T2 (de) 1995-10-05
JPH03209398A (ja) 1991-09-12
ES2071038T3 (es) 1995-06-16
EP0620010A1 (en) 1994-10-19
EP0426314A2 (en) 1991-05-08
IE903604A1 (en) 1991-04-24
CA2027455A1 (en) 1991-04-13
EP0620009A1 (en) 1994-10-19
GR3015244T3 (en) 1995-06-30
HU906421D0 (en) 1991-04-29
HUT55035A (en) 1991-04-29
ATE119166T1 (de) 1995-03-15
NZ235538A (en) 1992-06-25
ZA907944B (en) 1991-10-30
AU6393990A (en) 1991-04-18
DE69017352D1 (de) 1995-04-06
CN1052310A (zh) 1991-06-19
EP0426314A3 (en) 1991-07-24

Similar Documents

Publication Publication Date Title
ATE373010T1 (de) Gag-antigen und dessen verwendung zum nachweis von lav-infektion, sowie in immunogenen zusammensetzungen
DE60026332D1 (de) Diagnose von einheimischer sprue/zöliakie mit hilfe von gliadinepitopen
ES2013346A6 (es) Metodos para producir secuencias y moleculas de adn recombinante, asi como proteinas t4 solubles.
DE68928130D1 (de) Synthetische vom HIV-GP120-env-Protein abgeleitete Peptide und ihre Anwendung
BR9500732B1 (pt) kit diagnóstico para a detecção de anticorpos contra vìrus que causam imunodeficiência.
WO1991009872A3 (en) Hiv-1 env fragment fusion protein
FR2669338B1 (da)
DK0491628T3 (da) Lipopeptider inducerende cytotoksiske T-lymfocytter og deres anvendelse som vacciner
DK0426314T3 (da) HIV-relaterede peptider
EP0330700A4 (en) Human prourokinase-like polypeptide.
ATE270333T1 (de) Von proteinen des hepatitis c-virus abgeleitete polypeptide und deren verwendung
FR2694938B1 (fr) Nouveaux peptides, anticorps diriges contre ces peptides, anticorps anti-idiotypiques, application a titre de medicaments, compositions pharmaceutiques et kits de diagnostic les renfermant.
PT87239A (pt) Process for the preparation of peptides
DK0811067T3 (da) Equin arteritisviruspeptider, antistoffer og deres anvendelse i en diagnostisk test
DE69012989D1 (de) Peptiden von retinblastoma gen produkten und antikoerper dagegen.
TH9844A (th) เพพไทด์ที่สัมพันธุ์ hiv
SE8705197D0 (sv) New peptides, two diagnostic methods using the peptides and a medicament based on the peptides
TH13136A (th) แอนติเจนของ hiv
TW369600B (en) Antigenic peptides for grouping hepatitis C virus, kit comprising the same and methods for its grouping the same